-
Featured Authors
-
Archives
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: company presentations
BUZZ of BIO Winners Announced for the 2016 BIO Investor Forum
BIO is pleased to announce the winners of the 2016 BIO Investor Forum Buzz of BIO contest, which recognizes highly innovative companies in the biotech sector. Ten pioneering biotech companies were nominated in each of two categories—Early Stage Entrepreneurs and Late Stage Leaders; voting closed August 23. Sequella, a private, clinical-stage pharmaceutical company, won in the Early Stage Entrepreneurs category. The company is focused on antibiotic-resistant bacterial diseases and improved treatments for serious infectious diseases. Sequella’s stated business Read More >
Win a Free Company Presentation at the 2016 BIO Investor Forum
Nominations are now open for the Buzz of BIO contest at the 2016 BIO Investor Forum. The Buzz of BIO contest recognizes highly innovative companies in the biotech sector and helps position these companies to develop strategic partnerships within the industry. Ten biotechs will be nominated in each of two categories – Early Stage Entrepreneurs and Late Stage Leaders. Early-stage companies looking for their next financing round or late-stage companies hoping to make the valuable connections needed to take Read More >
The Week Ahead for Partnering
As mentioned in our twitter feed, BIO Business Forum and Exhibitor Partnering has surpassed the number of requests in the system over last year’s totals. Over 130,000 partnering meeting requests are off in cyberspace, and close to 22,000 meetings already scheduled. This includes about 4,900 exhibitor partnering meetings, which is another stat beating last year’s numbers. We’ve been excited about the addition of exhibitor partnering, and it’s been great to see the adoption by the exhibitors themselves. Read More >
How BIO Helps Save Biotech Companies Money
We all know that economic conditions and policy can affect the growth rate and sustainability of companies within the biotech industry. Whether a company is seeking an investment deal, creating partnership opportunities, or applying for FDA approval, BIO’s goal is to create avenues that will support the innovation of its member companies. While some folks within the BIO organization focus on BIO’s mission by providing policy, advocacy and communication services, the Business Solutions team, simply Read More >
